中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 近代物理研究所
  3. 中国科学院近代物理研究所
Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells

文献类型：期刊论文

作者Zhao,Xueshan1,5; Jin,Xiaodong2; Zhang,Qiuning2,3,4; Liu,Ruifeng2,3,4; Luo,Hongtao2,3,4; Yang,Zhen2; Geng,Yichao1; Feng,Shuangwu1; Li,Chengcheng1; Wang,Lina1
刊名Cancer Cell International
出版日期2021-12-04
卷号21期号:1页码:12
关键词LncRNA H19 MiR-130a-3p WNK3 Non-small-cell lung cancer Radiotherapy
DOI10.1186/s12935-021-02268-1
通讯作者Wang,Xiaohu(xhwang@impcas.ac.cn) ; Li,Qiang(liqiang@impcas.ac.cn)
英文摘要AbstractBackgroundThe lncRNA H19 is believed to act as an oncogene in various types of tumors and is considered to be a therapeutic target and diagnostic marker. However, the role of the lncRNA H19 in regulating the radiosensitivity of non-small cell lung cancer (NSCLC) cells is unknown.MethodsThe expression profiles of lncRNAs in NSCLC were explored via transcriptome sequencing. CCK-8, EdU incorporation and clonogenic survival assays were conducted to evaluate the proliferation and radiosensitivity of NSCLC cells. Flow cytometry and Western blotting were conducted to measure the level of apoptosis. The binding relationship between the lncRNA H19 and miR-130a-3p was determined by a dual-luciferase reporter assay. A binding relationship was also identified between miR-130a-3p and With-No-Lysine Kinase 3 (WNK3).ResultsExpression?patterns of lncRNAs revealed that the lncRNA H19 was upregulated in radioresistant NSCLC (A549-R11) cells compared with A549 cells. Knockdown of the lncRNA H19 enhanced the sensitivity?of NSCLC cell lines to X-ray and carbon ion irradiation. Mechanistically, the lncRNA H19 serves as a sponge of miR-130a-3p, which downregulates WNK3 expression. The lncRNA H19–miR-130a-3p–WNK3 axis modulates radiosensitivity by regulating apoptosis in NSCLC cell lines.ConclusionKnockdown of the lncRNA H19 promotes the sensitivity of NSCLC cells to X-ray and carbon ion irradiation. Hence, the lncRNA H19 might function as a potential therapeutic target that enhances the antitumor effects of radiotherapy in NSCLC.
WOS关键词P38 MAPK INHIBITOR ; NONCODING RNA H19 ; LUNG-CANCER ; PRELIMINARY EFFICACY ; DOSE-ESCALATION ; PHASE 1/2A ; EXPRESSION ; BC-819 ; RALIMETINIB ; THERAPY
资助项目Science and Technology Plan Project of Chengguan District of Lanzhou[2020-2-2-5] ; Talent innovation and venture project of Lanzhou city[2020-RC-113] ; Talent innovation and venture project of Lanzhou city[2017RC-23] ; Lanzhou KejinTaiji Corporation, Ltd[BMP-B-02-002] ; Key Deployment Project of Chinese Academy of Sciences[KFZD-SW-222]
WOS研究方向Oncology
语种英语
WOS记录号BMC:10.1186/S12935-021-02268-1
出版者BioMed Central
资助机构Science and Technology Plan Project of Chengguan District of Lanzhou ; Talent innovation and venture project of Lanzhou city ; Lanzhou KejinTaiji Corporation, Ltd ; Key Deployment Project of Chinese Academy of Sciences
源URL[http://119.78.100.186/handle/113462/138257]  
专题中国科学院近代物理研究所
通讯作者Wang,Xiaohu; Li,Qiang
作者单位1.Lanzhou University; The First School of Clinical Medicine
2.Chinese Academy of Sciences; Institute of Modern Physics
3.University of Chinese Academy of Sciences
4.Lanzhou Heavy Ion Hospital
5.Affiliated Hospital of Qinghai University
推荐引用方式
GB/T 7714		 Zhao,Xueshan,Jin,Xiaodong,Zhang,Qiuning,et al. Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells[J]. Cancer Cell International,2021,21(1):12.
APA Zhao,Xueshan.,Jin,Xiaodong.,Zhang,Qiuning.,Liu,Ruifeng.,Luo,Hongtao.,...&Li,Qiang.(2021).Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells.Cancer Cell International,21(1),12.
MLA Zhao,Xueshan,et al."Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells".Cancer Cell International 21.1(2021):12.

入库方式： OAI收割

来源：近代物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。